Study S002436

A Phase I, Randomized, Single-dose, 3-Period, Open-Label Study to Assess the Pharmacokinetic Formulation Bridging, Safety, and Food Effect of Different Oral Formulations of AZD5004 in Healthy Participants

ClinicalTrials.gov record

Registration

Registration: NCT07455825
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 65
Start: 2026-03-05
Primary completion: 2026-06-01
Lead sponsor: AstraZeneca
Conditions: Healthy Participants
Interventions: DRUG:AZD5004
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Area under concentration-time curve from time 0 extrapolated to infinity (AUCinf) [From Day 1 to Day 22]
Area under concentration-curve from time 0 to the time of last quantifiable concentration (AUClast) [From Day 1 to Day 22]
Maximum observed concentration (Cmax) [From Day 1 to Day 22]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.